Risk of congenital anomalies detected during antenatal serum screening in women with pregestational diabetes
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Most studies comparing women with and without pregestational diabetes mellitus have not systematically screened for fetal anomalies in early pregnancy, potentially leading to selection bias. AIM: To evaluate the risk for certain congenital anomalies in women participating in an antenatal maternal screening program. DESIGN: Retrospective cohort study. METHODS: We studied all women who underwent antenatal maternal serum screening in Ontario from 1994 to 2000. Fetal anomalies were documented antenatally by ultrasonography or at autopsy, and postnatally diagnosed birth defects were recorded after 20 weeks gestational age for all live- and stillborn affected infants. We compared the risk of open neural tube defects and urinary tract defects among women with and without pregestational diabetes. RESULTS: Of 413,219 women screened during pregnancy, 2069 (0.5%) had diabetes. Compared to non-diabetic women, the adjusted odds ratios (95%CI) for neural tube and urinary tract defects among women with diabetes were 2.5 (0.9-6.8) and 2.6 (1.4-4.9), respectively. DISCUSSION: Among women who undergo second trimester maternal serum screening, pregestational diabetes is associated with an increased risk of having a fetus with an open neural tube defect or urinary tract disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pregnancy outcomes in the Diabetes Control and Complications Trial
(1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70683-x · Cited by 278
Cited by
Etiology, pathogenesis and prevention of neural tube defects
Padmanabhan, R. (2006) · Congenital Anomalies · doi:10.1111/j.1741-4520.2006.00104.x · Cited by 297
Preconception care: nutritional risks and interventions
Dean, S. V., Lassi, Z. S., Imam, A. M., & Bhutta, Z. A. (2014) · Reproductive Health · doi:10.1186/1742-4755-11-s3-s3 · Cited by 279
Wahabi, H. A., Fayed, A., Esmaeil, S., Elmorshedy, H., Titi, M. A., Amer, Y. S., Alzeidan, R. A., Alodhayani, A. A., Saeed, E., Bahkali, K. H., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0237571 · Cited by 130
Wahabi, H. A., Alzeidan, R. A., & Esmaeil, S. A. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-792 · Cited by 126
“Background Pre-gestational diabetes mellitus (PGDM) and maternal hyperglycemia during the time of organogenesis is a known teratogen with detrimental effects on the fetal heart, renal, musculoskeletal and central nervous systems [1-3].”
BackgroundInsulin Use in Pregnancy: An Update
Blum, A. K. (2016) · Diabetes Spectrum · doi:10.2337/diaspect.29.2.92 · Cited by 59
“This risk is associated with both frequent and severe hyperglycemia before conception and during organogenesis (5–8 weeks after the last menstrual period) (4,5).”
Background
Metadata
- Authors
- Ray, J. G., Vermeulen, M. J., Meier, C., & Wyatt, P. R.
- Venue
- QJM: An International Journal of Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-10
- Volume
- 97
- Issue
- 10
- Pages
- 651-653
- ISSN
- 0033-5622 (ISSN-L)
- 1460-2393
- 1460-2725
- OpenAlex
- W2065300129
- Cited by
- 54
- References
- 1
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk of congenital anomalies detected during antenatal serum screening in women with pregestational diabetes. https://app.cochat.ai/papers/10.1093/qjmed/hch107
- The paper
- Ray, J. G., Vermeulen, M. J., Meier, C., & Wyatt, P. R. (2004). Risk of congenital anomalies detected during antenatal serum screening in women with pregestational diabetes. QJM: An International Journal of Medicine. https://doi.org/10.1093/qjmed/hch107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.